Tuesday, 02 January 2024 12:17 GMT

420 With CNW - Georgia House Approves Bill Easing Medical Marijuana Program Access


Date:

(MENAFN- Investor Brand Network) The Georgia House of Representatives has approved medical marijuana legislation designed to broaden patient access. The proposal cleared the chamber with strong bipartisan support, passing 138 to 21.

The measure now returns to the Senate for final consideration before the legislative session concludes on April 2. The steps so far taken to ease access to medical marijuana in Georgia will be seen by the broader industry and entities like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) in other states as...

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: /Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MENAFN18032026000224011066ID1110881000


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search